Recurrent oedema associated with the co-formulation of lopinavir and ritonavir.
Pinto
Jorge Francisco C
JF
Eyer-Silva
Walter A
WA
Morais-de-Sá
Carlos Alberto
CA
D000328:Adult; D004487:Edema / Q000139:chemically induced*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects*
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir